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Generalized Resistance to Thymic Deletion in the
NOD Mouse: A Polygenic Trait Characterized
by Defective Induction of Bim
CD48, and CD425 thymocytes. Resistance to thy-
mic deletion does not reflect a general deficit in TCR
signaling to calcineurin- orERK-inducedgenes, imbal-
ance in constitutive regulators of apoptosis, nor ex-
cessive signaling to prosurvival genes but is distin-
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NOD mouse (Kishimoto and Sprent, 2001; Lesage et al.,lar complexity. Here, we pinpoint the action of a sub-
set of autoimmune susceptibility loci in the NOD 2002). Kishimoto and Sprent showed that semimature
thymocytes from NOD, intermediate between the imma-mouse strain linked to D1mit181,D2mit490, D7mit101,
and D15mit229, which cause a generalized resistance ture CD48DP cells andCD48SP cells, are relatively
resistant to cell death in vitro when their TCRs are cross-to thymic deletion in vivo that applies equally to
Aire-induced organ-specific gene products in the thy- linked with different doses of anti-TCR antibody, al-
though this finding has been disputed (Villunger et al.,mic medulla and to systemic antigens expressed at
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strains (Lesage et al., 2002). These cells were deleted
during the transition between DP and SP cells in the
thymus of autoimmune resistant B10.Br strain mice, but
not in the NOD.H2k strain where the T cells escaped to
the periphery and progression to diabetes ensued. The
NOD defect in thymic deletion was comparable in mag-
nitude to that caused by deficiency of Aire in the same
model (Liston et al., 2003); however, the NOD defect
acted cell autonomously within autoreactive T cells car-
rying the non-MHC NOD genes (Lesage et al., 2002).
This in vivo NOD defect in negative selection has re-
cently been extended to theCD8 thymocyte population
in the AI4 transgenic model, indicating that it is not
isolated to the CD4 lineage alone nor to the 3A9 trans-
gene (Choisy-Rossi et al., 2004).
The basis for T cell resistance to thymic deletion in
NOD mice is unknown. It is not known if this resistance
is uniquely associated with thymic deletion to Aire-
induced antigens encountered late in differentiation in
the thymic medulla or if it might relate to the systemic
autoimmune syndromes that also occur in NOD strains
nor is it known if this defect explains the action of one
or more of the twenty-two known insulin dependent
diabetes (Idd) or other autoimmune susceptibility loci in
NOD. Here, we analyze these issues by a combination
of in vivo cellular, molecular, and genetic approaches
and find that there is a global, quantitative decrease in
the efficiency of clonal deletion within the DP, SP, and
CD425 thymocyte subsets across a rangeof amounts,
locations, and sources of antigen. In molecular terms,
the defect is explained by selectively diminished induc-
tion of Bim and reflects the additive action of four NOD
loci, previously largely associated with diabetes and
other autoimmune disorders in NOD mice and encom-
passing the Bim locus itself.
Results
Figure 1. HEL Protein Expression in Thymi of Transgenic Mice
Defective Thymic Deletion to Four Different Sections of frozen thymi from nontransgenic, insHEL, TgHEL,
Sources of Autoantigen MtHEL, and H2-K:HEL transgenic B10.Br and NODk mice were
stained with antibodies to HEL (green) and keratin (gray) and exam-Thymic deletion of T cells bearing NOD or B10 genetic
ined by confocal microscopy. The thymic medulla (M) and cortexmakeup was analyzed in vivo across a range of sources
(C) are indicated. Data are representative of three experiments.and amounts of thymic antigen to determine if NOD
resistance to thymic deletion was limited to particular
stages of development and sources of antigen. Four
nofluorescence (Figure 1) associated withAire-dependentdifferent HEL transgenic strains were backcrossed to
deletion (Liston et al., 2004). The Mt:sHEL transgenic3A9 TCR transgenic mice on the B10.Br and NOD.H2k
strain ML4 encodes soluble HEL driven by the metallo-(NODk)MHC-congenic strain backgrounds. The ins:mHEL
thionein promoter giving only a trace basal expressiontransgenic strain synthesizes high concentrations of
in the serum (Adelstein et al., 1991) and immunofluores-membrane bound HEL as a self antigen in pancreatic
cent staining in medullary epithelial cells comparable toislet  cells under control of the rat insulin promoter
the thyroglobulin promoter (Figure 1), although this is(Akkaraju et al., 1997b). Trace quantities of cleaved solu-
predominantly Aire-independent (A.L., unpublished data).ble HEL (sHEL) are present in the circulation of these
The H2-K:mHEL transgenic strain encodes the mem-mice (Akkaraju et al., 1997b), and Aire-dependent ec-
brane bound form of HEL being expressed under thetopic expression occurs in the thymus (Liston et al.,
H2-Kb promoter, driving ubiquitous high-level expres-2004) with trace immunofluorescent staining in rare
sion on radioresistant cells and thymocytes (Figure 1;medullary cells (Figure 1). The Tg-HEL transgenic strain
Hartley et al., 1991), and is unaffected by Airemutationsencodes the same membrane bound HEL protein under
(Liston et al., 2004). For each transgene, HEL expressionthe control of a fragment of the rat thyroglobulin pro-
in the thymus was equivalent on the B10.Br and NODkmoter, resulting in high expression in the thyroid epithe-
backgrounds as measured by immunofluorescencelium, undetectable levels of sHEL present in the circula-
(Figure 1; histograms shown in Supplemental Figure S1tion (Akkaraju et al., 1997a, 1997b), and expression in
scattered thymic medullary epithelium detected by immu- available online at http://www.immunity.com/cgi/content/
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Figure 2. Cellular Effects of Thymic HEL Expression on 3A9 T Cells in B10.Br and NODk Genetic Backgrounds
Development of 3A9 TCR-bearing cells was analyzed by flow cytometry in TCR transgenic and the indicated TCRHEL double transgenic
mice on the B10.Br and NODk backgrounds. (A) Representative CD4 versus CD8 profiles of thymocytes. (B) Mean number of CD4CD8
double positive thymocytes. B10.Br strains are shown in black, NODk strains are shown in white, error bars represent the SD. Significance
of differences between B10.Br and NODk groups of the same genotype are indicated by t test p values about the group. (C) Representative
profiles showing staining with the 3A9 TCR clonotypic-specific antibody 1G12 and CD69, gated on CD4CD8 SP thymocytes. (D) Mean
number of mature CD69 1G12hi CD4 single positive thymocytes. Significance of differences between B10.Br and NODk groups of the same
genotype are indicated by t test p values above the group. (E) CD4 and clonotypic 1G12 staining within splenic lymphocytes. (F) Mean
percentage of splenocytes that are CD41G12. Significance of differences between B10.Br and NODk groups of the same genotype are
indicated by t test p values above the group. (G) A pairwise comparison of NODk and B10.Br counterparts, illustrating the relative deletion
of immature (CD4CD8) and mature (CD4CD81G12CD69) cells under each condition and showing the resistance to deletion in each of
the NODk transgenic strains (open symbols) relative to their B10.Br counterparts (closed symbols) for the same concentration of thymic HEL.
full/21/6/817/DC1/) as were serum levels of sHEL protein the major subsets (Figure 2A), with further subdivision
of the CD4 SP subset based on staining with the 1G12(data not shown).
While there was no detectable effect of the NOD strain antibody specific for the 3A9  TCR clonotype and for
CD69 (Figure 2C). Large numbers of mature 1G12hiCD69background upon thymic antigen expression, we next
investigated how the NOD versus B10 background af- SP cells and semimature CD4 1G12hiCD69 SP cells
were present in the thymus of B10.Br and NODk 3A9fected thymic deletion in TCRHEL double transgenic
mice bearing each of the HEL transgenes (Figure 2). transgenic mice in the absence of HEL (Figure 2D). In
TCRHEL double transgenic mice carrying the differentT cell differentiationwas tracedby four color flow cytom-
etry, measuring CD4 and CD8 expression to distinguish HEL transgenes, these SP subsets and the DP cells
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underwent graded degrees of clonal deletion as gauged the autoreactive SP cells in Tg, Mt, and H2-K mice on
by decreased cell frequency and absolute numbers, and the B10 backgroundwith the higher levels of thymic HEL
in each case, deletion was markedly less efficient in the (Figure 3B). In the NOD counterparts of these animals;
NOD animals. First, when comparing the numbers of DP however, little increase in the proportion of CD25 cells
cells in double transgenic mice to those in TCR-only occurred under the insulin promoter, rising to 30% in
controls (Figures 2B and 2G), we found that their number the Tg and Mt animals and only reaching the plateau of
was decreased 50% in B10.Br TCRinsHEL double 50% in the H2-K animals. The increase in proportion of
transgenic mice, whereas no significant decrease was CD4cells that bear theCD25marker is nevertheless not
triggered by insHEL in the NOD counterparts. DP cell due to any increase in absolute number of this subset,
numbers were reduced more markedly, to 10% of con- because the thymic presence of HEL actually results in
trols, in B10 mice with the thyroglobulin- or metallothio- a decrease in the absolute number of mature CD25
nein-regulated transgenes, which are expressed at thymocytes (Figure 3C). The same increase in propor-
higher levels in thymic medulla. Deletion of DP cells was tion, but not absolute numbers, of CD25 cells with the
now detected in the NOD counterparts but only to the presence of self-antigen is also observed in TCRins-
levels achieved in B10 mice with the lower amounts of HEL double transgenic B10.Br TCR0/0 and RAG0/0 mice,
thymic HEL from the insulin promoter so that five times establishing that these cells do not require another re-
more DP cells remained. DP cells were almost com- ceptor chain for their formation (data not shown). Plot-
pletely absent in B10 mice with the highly expressed ting the relationship between mean numbers of CD25
H2-K:HEL transgene (Figure 2A), whereas five times and CD25 CD41G12 cells in the different groups
more DP cells again remained in the NOD counterparts reveals that the CD25 population appears remarkably
so that deletion only attained the levels observed in B10 refractory to thymic deletion and only shows evidence
mice with the much less expressed TgHEL or MtHEL for a numerical reduction in B10 strains with higher thy-
transgenes (Figures 2B and 2G). mic antigen expression (Figure 3D).
In the same panel of mice, thymic deletion of mature
CD4CD81G12hiCD69 cells (Figure 2C) was also NOD Effects on Gene Responses Mediating
graded but appeared more efficient than in the DP sub- Negative and Positive Selection
set and exhibited an even greater magnitude of defect Thedata above indicate ageneral, quantitative decrease
in the NOD counterparts (Figures 2D and 2G). Mature in the efficiency of clonal deletion affecting three key
HEL-reactive thymocyteswere reduced to 3%of control thymocyte subsets. Because the NOD effect acts cell
numbers in insHEL mice on the B10.Br background, autonomously within the T cells, it could arise from a
whereas they were only decreased to 30% of controls global reduction in efficiency of TCR signal transmis-
in the NODk background so that more than ten times sion, heightened signaling to prosurvival pathways, se-
as many autoreactive cells remained. In the Tg and Mt lective decrease in TCR signaling of apoptosis, or a shift
transgenic strains with higher HEL expression in the in the balance of pro- and antiapoptotic effectors. To
thymic medulla, mature cells were decreased to 0.3% resolve these alternatives, we gauged their in vivo activ-
of controls, whereas fifteen times higher numbers re-
ity before and during negative or positive selection by
mained in the NOD counterparts so that deletion only
flow sorting discrete subsets of thymocytes from NOD
attained the efficiency of B10 animals with insHEL. In
and B10 counterparts and then measuring mRNAs for
the H2-K:HEL animals, the numbers of mature cells in
genes that are well-defined targets and mediators ofthe NOD group were reduced to 0.2% of controls, but
these processes. Four subsets of thymocytes werethis magnitude compared only with the B10 animals
sorted from both B10.Br and NODk counterparts (Figureexpressing much less thymic HEL from Tg or Mt trans-
4A). The subset of DP cells that are negative for CD69genes. The generalized decrease in efficiency of clonal
and 1G12 TCR clonotype (“early DP”) was sorted fromdeletionwas also apparentwhen peripheral CD41G12
TCR and TCRinsHEL double transgenic mice to obtaincells were enumerated in the spleen (Figures 2E and
cells that had not yet received positive or negative selec-2F). When the mean number of DP and mature SP cells
tion signals. Cells thatwere in the early stagesof positivein the thymus were plotted, the relationship between
selection (“early SP”) were sorted from TCR animalsdeletion in DP and mature cell subsets appears un-
lacking HEL based upon the cell surface phenotype ofchanged by the NOD background, but deletion is shifted
CD4CD8lowCD691G12, and cells in the early stagesup the curve by between 5- and 15-fold for each source
of negative selection (“early SP”) were sorted based onof antigen (Figure 2G). Thus, the NOD thymic deletion
the same phenotype from double transgenic animals.defect is not limited to organ-specific promoters ex-
These four types of cells were sorted frommultiple NODpressed in thymic medulla but manifests at early and
or B10 animals under conditions designed to preventlate stages of maturation and low or high amounts of
any gene induction ex vivo to yield three biologicallythymic autoantigen.
and technically independent pools of mRNA for each of
the eight experimental groups. After RNA purificationDefective Thymic Enrichment of CD425 Cells
and double amplification, labeled cRNA was hybridisedAs an alternative to clonal deletion, thymic encounter
to Affymetrix 430A GeneChips, and the data analyzedwith autoantigen can also result in apparent conversion
by MAS software.of autoreactive CD4 cells to CD25 regulatory cells that
The microarray dataset was first verified by analyzingare exported from the thymus rather than being deleted
relative mRNA values for genes with a well-established(Jordan et al., 2001). Consistent with these results is the
role and expression pattern during thymocyte matura-finding that a much greater fraction of CD41G12 SP
tion, either decreasing during differentiation from DP tothymocytes are CD25when a HEL transgene is present
(Figure 3A), and this proportion plateaus at 50% of SP cells (Cd8, Rag1, Rag2, and preT, Figure 4B) or
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Figure 3. Production of CD4CD25 Thymocytes in B10.Br and NODk Transgenic Strains
TCR and double transgenic mice on the B10.Br and NODk backgrounds were assessed for CD4CD25 thymocyte production by flow
cytometry. (A) Representative profiles for CD25 versus 1G12 clonotype, gated on CD4 SP thymocytes. (B and C) Mean percentage (B) and
number (C) of mature CD4CD81G12 thymocytes expressing CD25. B10.Br strains are shown in black, NODk strains are shown in white.
Error bars represent the SD. Significance of differences between B10.Br and NODk groups of the same genotype are indicated by t test p
values about the group. (D) A pairwise comparison of NODk and B10.Br counterparts, illustrating the relative deletion of CD25 and CD25
semimature (CD4CD81G12) thymocytes under each condition and showing the resistance to deletion in each of the NODk transgenic
strains (open symbols) relative to their B10.Br counterparts (closed symbols) for the same concentration of thymic HEL.
increasing in SP cells (Cd4, Ccr7, S1pr1, and Il7R, Fig- pression levels were too low to identify any consistent
changes in the other samples.ure 4C). Each of these mRNAs showed dramatic and
highly reproducible changes in expression between DP Sets of previously identified reporter genes were ana-
lyzed to measure the strength of major signaling path-and SP cell populations as expected with minor differ-
ences between negative and positive selecting thymi ways to address the hypothesis of a global reduction in
efficiency of TCR signal transmission.We first examinedand between B10 and NOD counterparts.
Considering thedata above showing that an increased a set of genes induced by the TCR-calcineurin-NFAT
signaling pathway based upon microarray analysis ofproportion of CD41G12 cells are CD25 in TCRins-
HEL animals on the B10 background, we then examined calcineurin B-deficient thymocytes:Egr2, lan1,Adam19,
Itgb7, CD52, and Bach2 (E.G. and G.C., unpublishedthe data for a set of mRNAs established by others as
being increased in peripheral CD425 T regs (McHugh data). All of these genes showed induction during devel-
opmental progression from DP to SP stages, little oret al., 2001). Consistent with the flow cytometry, Cd25
mRNA was selectively increased in negatively selecting no significant difference between positive and negative
selection, and no strain differences between B10.Br andSP cells from B10 mice, but not in NOD counterparts
(Figure 5A). Parallel increases in Gitrd, Pcd1, 4-1bb, NODk (Figure 5B). Because the ras-MEK-ERK-TCFpath-
way is also activated and required for TCR-mediatedOx40, andCtla4occurred in negatively selectingSPcells
from B10 animals, and these also failed to be increased positive selection, we examined a set of genes known
to be targets of this pathway. Egr-1, fos, zfp36l1, andmarkedly in the NOD counterparts with the exception
of Ctla4, which was equally increased in the NOD cells. Nab2were all induced in early SP cells undergoing posi-
tive selection or negative selection (Figure 5C); however,Foxp3 mRNA was consistently present only in the B10
negatively selecting population replicates; however, ex- there was again no significant differences between NOD
Immunity
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Figure 4. Experimental Design and Verification of Microarray Analysis of Sorted Thymocyte Subsets
(A) Thymocytes from TCR transgenic and TCR:insHEL double transgenic (Dbl) nondiabetic 6- to 8-week-old female mice on the B10.Br and
NODk backgrounds were sorted into the indicated subsets. Three biological replicate pools of mRNA were generated for each subset with
independent sorts. Because of lower cell numbers, B10.Br Dbl early single positive cells were pooled from multiple independent donor mice.
These replicate mRNA pools were independently labeled and hybridized to Affymetrix m430A arrays, and the average expression level for
representative genes in each sample is shown by the square symbols in (B) and (C).
(B) Expression levels measured for representative well-characterized genes known to be developmentally downregulated between the early
double positive stage and the early single positive stage.
(C) Expression levels of genes that are well established to be developmentally upregulated between the early double positive stage and the
early single positive stage. Individual values of biological replicates are represented in black (B10.Br) and white (NODk) boxes.
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Figure 5. Expression of Known CD425 Regulatory T Cell Markers and Targets of Calcineurin and Erk Signaling in Thymocytes
(A) Genes known to be increased in CD4CD25 regulatory cell subset.
(B) Calcineurin response genes.
(C) ERK response genes. Individual values are represented in black (B10.Br) and white (NODk) boxes with significant differences between the
strain backgrounds indicated above the plot.
and B10 strains. By these downstream measures, both or a constitutive shift in the balance of pro- and antiapo-
ptotic terminal regulators. An important prosurvivalthe calcineurin and ERK pathways appear to signal nor-
mally during positive and negative selection of NOD thy- pathway activated by the TCR comprises various mem-
bers of the NFB family. Analysis of NFB1/p105,mocytes.
We next tested the alternative hypotheses of selec- NFB2, Bcl-3, c-rel, rel-B, IB, and IB showed that
all except p65/rel A and IB were induced in earlytively heightened signaling to prosurvival pathways, se-
lectively diminished signaling of proapoptotic effectors, SP cells undergoing positive and negative selection,
Immunity
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Figure 6. Expression of Genes Known to Regulate Apoptosis
(A) Expression of known antiapoptotic genes.
(B) Known proapoptotic genes. Individual values are represented in black (B10.Br) and white (NODk) boxes with significant differences between
the strain backgrounds indicated above the plot.
(C) Flow cytometry analysis of Bim protein (tinted) in CD41G12 thymocytes, comparing CD41G12 thymocytes under positive (TCR
transgenic) and negative (TCR:insHEL double transgenic) selection on the B10.Br and NODk backgrounds with the percentage of Bim cells
indicated on the graph. Staining specificity is indicated through parallel staining of Bim0/0 thymocytes (line, background of 0.8% Bim cells).
generally to highest levels in negative selection (Figure NFB1/p105 and c-rel were less induced in NODk early
SP cells undergoing negative selection.6A). None were significantly overinduced in NODk thy-
mocytes compared with B10 counterparts, and, in fact, Analysis of constitutively expressed pro- and antiapo-
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ptotic regulators showed no significant differences in mice (Lesage et al., 2002). In the backcross, the TCR
and insHEL transgenes segregated independently inexpression of Bcl-2, mcl-1, Bax, Bak, Bad, noxa, puma,
caspase 9, caspase 3, and apaf-1 in B10.Br and NODk hemizygous state, because neither of these can be fixed
as homozygotes. A total of 1906 backcross mice werethymocytes (Supplemental Figure S2), arguing against
the hypothesis of a shift in favor of constitutive antiapo- bred, 979 female offspring weaned and genotyped for
HEL and TCR transgenes, and 149 double transgenicptotic molecules. Analysis of the components of the
TCR-activated Fas apoptotic pathway showed induc- backcross animalswere identified and their thymus ana-
lyzed for efficiency of clonal deletion. As shown in Fig-tion of FasL in early SP cells undergoing negative selec-
tion that was not different between NOD and B10 cells ures 2 and 3, defective negative selection in the NOD
animals is characterized by an increased frequency of(Figure 6B).Other elements of this pathway—Fas,FADD,
Casp8, and cFlip—showed no significant induction or 1G12hiCD69CD4 SP cells and by failure to increase the
proportion of CD41G12 cells that are CD25, so thisstrain differences (Supplemental Figure S1). By contrast,
analysis of the two TCR-induced genes with clearly es- combination of parameters was used (Figure 7) to clas-
sify the 149TCRinsHELbackcrossmice into “deletors”tablished effector roles in thymic deletion, BimL and
Nur77, revealed striking deficits selectively in NOD early comparable to F1 controls (24%, n 35), “nondeletors”
comparable to NODcontrols (35%, n 52), and interme-SP cells undergoing negative selection. Consistent with
previous data (Bouillet et al., 2002; Villunger et al., 2004; diates (42%).
Next, the deletor and nondeletor animals were indi-Woronicz et al., 1994; Xue et al., 1997), BimL and Nur77
mRNAs were dramatically increased in B10.Br early SP vidually genotyped with SSLPs linked to seven major
NOD Idd loci: Idd2, Idd3/10/18, Idd4, Idd5, Idd6, Idd9/cells undergoing negative selection compared to their
positively selecting early SP counterparts (Figure 6B). In 11, and Idd13/Bim (Figure 7). Loci with a preponderance
of heterozygotes (B10/NOD) in the deletor cluster andnegatively selecting early SP cells from NOD, however,
there was no measurable increase in BimL and a signifi- homozygotes (NOD/NOD) in the nondeletor cluster, as
measured by contingency tables for 	2 values, were sug-cantly blunted increase in Nur77. Because of the essen-
tial function of Bim as an apoptotic initiator during thy- gestive for linkage to the NOD defect in thymic deletion.
Only two of these Idd regions showed evidence for link-mic deletion and previously defined posttranslational
regulation (Puthalakath et al., 1999), a flow cytometric age: a 	2 value of 4.6 (p  0.03, not Bayes corrected for
multiple testing) at the Idd5 locus on chromosome 1assay for intracellular Bimwasdeveloped. Amonoclonal
antibody, 10B12, with high specificity for Bim and no (Ch1) at D1mit181 (42.6 cM) and a 	2 value of 5.4 (p 
0.02, not Bayes corrected) at the Idd13 locus on Ch2 atcrossreactivity to any other protein (L.A.O., A.S., and D.
Huang, unpublisheddata) was used tomeasure intracel- D2mit490 (64.5 cM) which is also linked to the Bim gene
(59 cM).lular Bim levels in fixed and permeabilized CD41G12
thymocytes. Using theBim0/0mouse as a staining control A scan of other chromosomal regions was then per-
formed to assess the overall genetic complexity of the(Bouillet et al., 1999), we found Bim at just measurable
levels in CD41G12 thymocytes from the B10.Br and trait. This identified two additional NOD-derived regions
with highly significant associationwith resistance to thy-NODk TCR transgenic mice, which was dramatically in-
creased in vivo in SP cells undergoing negative selection mic deletion: a 	2 value of 11.3 centered on Ch7 at
D7mit101 (60 cM on the MGI map) and a 	2 value of 9.7fromB10.Br TCR:insHEL double transgenicmice (Figure
6C). Double staining for Bim and CD25 showed that centered on Ch15 at D15mit229 (22 cM). Paradoxically,
two loci showed an association between this trait andincreased Bim was limited to the CD25 subset (data
not shown). No detectable increase in Bim protein oc- inheritance of a B10-derived allele: a 	2 value of 10.3
centered on Ch13 at D13mit39 (37 cM) and a 	2 valuecurred in the corresponding SP cells in NODk double
transgenic mice. Collectively, these results establish of 8.1 centered on Ch14 at D14mit109 (3.3 cM). These
four regions correspond to loci previously associatedthat NOD thymocytes have a selective in vivo deficit
in autoantigen induction of proapoptotic effectors, in with autoimmunity in NOD mice, as discussed below,
and mathematical modeling was consistent with an ad-particular Bim.
ditive interaction among these loci and those identified
on Ch1 and Ch2 (Supplemental Data). Thus NOD resis-Genetic Loci Causing Defective Thymic
tance to thymic deletion is a complex polygenic trait.Deletion in NOD
The failure to induceBim in autoreactiveNODSP thymo-
cytes is sufficient to explain their generalized defect Discussion
in thymic deletion, because Bim-deficient mice have a
profound defect in thymocyte negative selection, and The findings here pinpoint the cellular and molecular
action of a subset of autoimmune loci in the NOD strain,loss of a single gene copy causes a marked thymic
deletion defect and autoimmunity (Bouillet et al., 1999, showing that they cause a general, quantitative resis-
tance to thymic deletion in vivo across a range of thymic2002; Villunger et al., 2004).We thereforewished to know
if resistance to thymic deletionmapped to the Bim locus developmental subsets and thymic antigen sources and
amounts. In vivo mRNA analysis reveals that the NODor to a subset of autoimmune loci established previously
in theNOD strain. A backcrosswas established between genes cause a remarkably selective failure of thymic
autoantigen to induce Bim, which is an essential, gene(B10.BrNOD.H2k)F1 animals and NOD.H2k based upon
the earlier finding that defective negative selection in dose-limiting mediator of thymic deletion (Bouillet et al.,
2002; Villunger et al., 2004). Flow cytometric analysisNOD is “recessive,” because double transgenic F1 mice
display efficient negative selection comparable to B10.Br shows that Bimprotein is indeed induced in single T cells
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Figure 7. Linkage Analysis of NOD Resistance to Thymic Deletion
Thymi from 149 female TCR:insHEL B10.BrNODk backcross 1 mice were analyzed at 6–10 weeks of age for the proportion of mature CD69
1G12hi CD4 single positive cells among CD4 and CD48 thymocytes and for the proportion of CD4CD8 1G12 thymocytes expressing
Resistance to Thymic Deletion in the NOD Mouse
827
undergoing in vivo thymic deletion to anAire-dependent tion of thymocytes (Punt et al., 1994) and that B7 ligands
for CD28 are primarily expressed on medullary, but notantigen and that it fails to be induced in corresponding
NOD thymocytes. Genetic analysis shows that the Bim cortical, thymic epithelial cells (Degermann et al., 1994),
there is the distinct possibility that the NOD allelesgene is a candidate for contributing toNOD resistance to
thymic deletion, but this quantitative trait nevertheless dampen the NFB pathway. A qualitative change in TCR
signaling in NOD thymocytes diminishes activation ofremains polygenic, illustrating the complexity of autoim-
mune susceptibility even when reduced to a simpler the zap70-ras-ERK pathway and enhances activation of
fyn and phosphorylation of c-cbl (Salojin et al., 1997). Itcellular trait.
The relationship between clonal deletion in the DP is unclear which TCR signaling pathway is responsible
for Bim induction at the transcriptional and protein lev-subset and in the most mature CD69 SP subset of
thymocytes, across the range of antigen amounts and els, although intracellular calcium (Bouillet et al., 1999,
2002) and cyclic AMP (Zhang and Insel, 2004) are impli-sources (Figure 2G), suggests a continuous curvilinear
function that is quantitatively, but not qualitatively, al- cated.
Under these conditions of limiting amount of antigentered by NOD genes.We propose the following explana-
tion for these data. In the insHEL animals, only rare under the insHEL transgene, it is interesting that we did
not observe overexpression of cFLIP in NOD thymo-antigen-presenting cells in the medulla and corticomed-
ullary junction display sufficient autoantigen/MHC com- cytes, contrary to previous in vitro data (Kishimoto and
Sprent, 2001). However, this is not inconsistent withplexes to induce Bim and trigger apoptosis, and these
are encountered infrequently as DP cells wander in the the findings by Kishimoto and Sprent, because the Fas
pathway appears to be of greater importance duringthymic cortex, receive positive selection signals, and
migrate into the medulla. Consistent with this hypothe- negative selection toward strong stimuli rather than the
weaker stimuli used in the present study (Kishimoto andsis, less than 50% of single positive cells bearing HEL-
reactive TCRs have induced Bim protein in B10.Br Sprent, 1999). Taken together, NOD thymocytes may
have defects in both the Bim and Fas apoptotic path-insHELTCR double transgenic thymi (Figure 6C). Be-
cause positive selection and maturation in the medulla ways, or a component common to both, with the differ-
ent pathways coming into play under different circum-appear to take many days (Scollay and Godfrey, 1995),
a high proportion of autoreactive thymocytes neverthe- stances.
Bim is also partially required for thymocyte apoptosisless experience a Bim-inducing encounter by the time
they reach the most mature CD69 stage, where much induced by 
 irradiation or dexamethasone (Bouillet et
al., 2002), andNODgene interferencewith Bim inductiongreater culling is evident in insHEL animals. In TgHEL
animals with greater antigen expression in thymic epi- by these stimuli might explain the resistance of NOD
thymocytes to 
 irradiation (Bergman et al., 2001) andthelial cells (Figure 1), more cells at the corticomedullary
junction may display enough peptide/MHC to induce dexamethasone (Bergman et al., 2003). Resistance to
dexamethasone maps to the Idd6 region on distal Ch6,Bim, resulting in more frequent apoptosis-inducing en-
counterswithin theDPsubset. By selectively depressing which showed insignificant association with resistance
to deletion (Figure 7), whereas NOD resistance to 
 radi-Bim induction to a given amount of autoantigen (Figure
6C), the NOD genes would be expected to reduce the ation-induced apoptosismaps to the Idd5 region of Ch1.
The Ctla4 gene within this interval is a candidate forfrequency of cell contacts with sufficient antigen to in-
duce apoptosis, accounting for the shift in deletion in radiation resistance because Ctla4-deficient thymo-
cytes are also radiation resistant (Bergman et al., 2001).NOD TgHEL animals to mirror deletion in B10 insHEL
animals (Figure 2G). The NOD Idd5 haplotype produces less of an alterna-
tively spliced Ctla4 gene product that is a constitutivelyNOD gene interference with Bim induction by autoan-
tigen does not appear to reflect a global interference active inhibitor of TCR zeta phosphorylation (Ueda et
al., 2003; Vijayakrishnan et al., 2004). The orthologouswith TCR signaling in thymocytes, because a range of
calcineurin-responsive or ERK-responsive genes in thy- region in humans also contains aCTLA-4 variant and has
been associated with diabetes, thyroid autoimmunity,mocytes are induced normally during positive and nega-
tive selection (Figure 5). On the other hand, several other Addison’s disease, and disease severity inmultiple scle-
rosis (Ueda et al., 2003). The association between thegenes that are induced to higher levels during negative
selection compared to positive selection (Nur77,NFB1, Idd5 region and in vivo resistance to thymic deletion is
significant at p  0.03 tested as a single hypothesis,c-rel, and A1) show significantly blunted induction in
NOD cells, although not to the extent of Bim, suggesting and the likelihood that this is a true positive is strength-
ened by the independent evidence associating this lo-that qualitative or quantitative changes in TCR signaling
may selectively interferewith activation of particular sig- cus with autoimmune susceptibility. Further confirma-
tion and analysis of this and the other associated NODnaling pathways. Because several of these genes are
induced by the NFB pathway (NFB1, c-rel, and A1) loci will nevertheless require the slow process of breed-
ing NOD congenic TCRinsHEL animals.and it has been previously shown that CD28 selectively
augments TCR activation of NFB and negative selec- The association between resistance to thymic dele-
CD25 as in Figures 2 and 3. Individuals were classified as nondeletors (25%, n  52), intermediates (42%), or deletors (24%, n  35) by
comparison to NODk and F1 controls. (A) Scatterplot showing separation of deletor and nondeletor mice. (B) Genotype data with Idd loci
(primary loci tested shown in bold) and marker positions on each chromosome from MGI v3. 	2 scores are shown when 4. Probabilities
shown are for single point values not corrected for multiple testing. Hom, homozygous for NOD allele; Het, heterozygous for NOD and B10 allele.
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tion and the region around D2mit490 at 64.5 cM on Ch2 to thymic deletion also match NOD loci associated with
is also supported by independent evidence. The Bim altered thymic selection and/or regulation: delayed on-
gene lies 11 Mb/5.5 cM proximal to D2mit490, making set of diabetes in NOD BCD2.5 TCR transgenic mice
it a good candidate gene for this association. Bim is at (Gonzalez et al., 1997) and reduced thymic positive se-
128.4 Mb (ENSEMBL), within the boundaries of the B6- lection of NKT cells in the NOD mouse (Esteban et al.,
derived Idd13 locus determining diabetes resistance in 2003). Both these traits were associated with the Idd13/
the NOD-derived strain, NOR (Serreze and Leiter, 1994), Bim region on Ch2. Diabetes in BDC2.5 was also associ-
and is within the proximal Idd13 sublocus as determined ated with the Idd5 region on Ch1 and with a region of
by subcongenic strains (Serreze et al., 1998) alongwith a Ch15 from 24 cM to 50 cM. Reduced thymic selection
diabetes-modifying polymorphism in -2 microglobulin of NKT cells was associated with the same region of
(Hamilton-Williams et al., 2001; Serreze et al., 1998). The Ch7 (D7mit101, 60 cM) identified here. In the NKT study,
association of resistance to thymic deletion with NOD the NOD alleles at each locus associate with reduced
alleles at Ch2 Idd13 and Ch1 Idd5 is notable, because thymic positive selection of NKT cells just as they are
these two loci act cooperatively in promoting T cell influx associated here with reduced thymic negative selection
into pancreatic islets (Fox et al., 2000). of conventional CD4 T cells. In the BDC2.5 study, the
Resistance to thymic deletion was strongly associ- NOD alleles at each locus are paradoxically associated
ated with NOD-derived loci on Ch7 at D7mit101 (60 cM) with resistance to diabetes. Unlike the 3A9 T cells stud-
and on Ch15 at D15mit229 (22.2 cM). The Ch7 region
ied here, BDC2.5 T cells are not deleted by the as-
corresponds to a NOD-derived diabetes susceptibility
yet unknown islet-derived peptide in either background,
loci defined byMcDuffie in a subcongenic strain (McDuf-
and resistance to diabetes depends upon peripheralfie, 2000) and to a locus at 58.7 cM, Ssial3, contribut-
regulation by other T cell specificities (Gonzalez et al.,ing to development of autoimmune sialoadenitis in a
2001). BDC2.5 TCR-bearing CD4 cells are less efficientlyNODNZW cross (Boulard et al., 2002). The fact that
positively selected on the NOD background (Gonzalezthis region has not been linked to diabetes in NODB10
et al., 1997). The concordance of loci mapped in thecrosses could be explained by the presence of a B10
three studies further strengthens the conclusion thatdiabetes susceptibility locus, Idd7, at the proximal end
these autoimmunity loci act by interfering with specificof Ch7 (Ghosh et al., 1993), which would interfere with
TCR signals for thymocyte selection.detection of linked NOD susceptibility loci and is absent
The magnitude of the thymic deletion defect causedfrom the subcongenic diabetes-resistant strain (McDuf-
by the NOD genes is only slightly less severe than thatfie, 2000). TheCh15 locus corresponds to a region show-
caused by homozygous Aire deficiency in the same 3A9ing suggestive evidence (	2  5) for association with
TCRinsHEL strain (Liston et al., 2003), and like Airediabetes in NODB10 (Ghosh et al., 1993). A locus in
deficiency in humans and mice, the generality of thisthe same region of Ch15 from the MRL strain, Paam1
defect is likely to play a key part in the susceptibilityat 18.7 cM, promotes progression of autoimmune arthri-
of NOD-derived strains to a range of different organ-tis in anMRL.lprC3H.lpr cross (Kamogawaet al., 2002).
specific diseases. Different autoantigens and tissuesNur77 is an unlikely candidate for the Ch15 linkage,
because it lies 4 Mb distal of D15Mit161 (	2  4). may become prime targets for this general defect
In addition to the four NOD-derived loci associated through variations in other genes such as MHC or B7.2
with resistance to thymic deletion, the trait becomes (Salomon et al., 2001; Todd and Wicker, 2001), perhaps
more complex in the backcross, because two B10- because these other genetic alterations selectively re-
derived loci on Ch13 and Ch14 were also strongly asso- duce thymic presentation and TCR induction of Bim by
ciated with resistance to deletion. Both the location and particular peptides and further increase the frequency of
“polarity” of these loci correspond with two regions autoreactive T cells against these targets. Our findings
where the B10-derived allele paradoxically associates show that it will be important to define the TCR pathway
with susceptibility to diabetes in B10NOD backcross for Bim induction and how it is genetically suppressed
mapping: Idd8 on Ch14 and an unnamed suggestive in order to develop tests for comparable cellular defects
locus (	2 5.6) on Ch13 (Ghosh et al., 1993). These B10- in human autoimmunediseases thatmight be performed
derived loci may account for the observation that B10.Br on peripheral blood T cells and to develop drugs that
TCRinsHEL animals develop a low incidence, early- augment this pathway to diminish the incidence of auto-
onset, autoantibody-negative diabetes that is clinically
immune disease in individuals with this susceptibility
distinct from the high-incidence, slower onset, autoanti-
trait.body-positive diabetes in NODk TCRinsHEL animals
and that is genetically distinct, because it is fully sup-
pressed in F1 hybrids (Lesage et al., 2002). Experimental Procedures
Considering as much as 20%–30% of the autosomal
Micegenome lies within 20 cM of an Idd locus, it would not
3A9 TCR transgenic mice (Ho et al., 1994), ILK-3 ins:mHEL trans-be surprising if two of the six loci detected overlap with
genic mice (Akkaraju et al., 1997b), KLK4 H2-K:mHEL transgenicknown Idd loci by chance and one in six to overlap
mice (Hartley et al., 1991), TLK3 Tg:mHEL transgenic mice (Akkarajuwith the correct polarity (i.e., NOD versus B10 allele
et al., 1997a, 1997b), and ML4 Mt:sHEL transgenic mice (Adelsteinassociated with susceptibility). However, the fact that
et al., 1991) were produced in C57BL/6J and backcrossed to B10.Br/
all six loci overlap with correct polarity very compellingly SgSnJ (JAX) or NOD.H2k (Podolin et al., 1993). Data presented are
argues that the thymic deletion defect is important to from N8–N10 for B10.Br mice and N6 for NODk mice. TCR, HEL,
the pathogenesis of diabetes in the NOD mouse. and H2 genotype of each mouse was tested twice by PCR (Akkaraju
et al., 1997b). Bim0/0 mice were as described (Villunger et al., 2004).The chromosomal regions associated with resistance
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reer Development Award (NHMRC).and 647 nm) by using the Bio-Rad acquisition software LaserSharp
version 3.2.
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